HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arteriovenous grafts are associated with earlier catheter removal and fewer catheter days in the United States Renal Data System population.

AbstractOBJECTIVE:
Arteriovenous fistulas (AVFs) are associated with improved long-term outcomes but longer maturation times and higher primary failure rates compared with arteriovenous grafts (AVGs). The Fistula First Breakthrough Initiative has recently emphasized tunneled dialysis catheter (TDC) avoidance. We sought to characterize the relationship of AVFs and AVGs to the use of TDCs as well as secondary procedures.
METHODS:
Using the United States Renal Data System (USRDS) database, we identified incident hemodialysis (HD) patients in 2005 that started HD with a TDC and survived at least 1 year. We then monitored them through 2008. Access creation, TDC removal, TDC placement, and secondary procedures were identified by Current Procedural Terminology codes (American Medical Association, Chicago, Ill). Multivariate logistic regression was used to identify risk factors for the primary end points.
RESULTS:
In 2005, HD was initiated in 56,495 patients, 74% with a TDC. Of these, 6286 had an access procedure ≤3 months and 1 year of follow-up (AVF, 4634; AVG, 1652). Mean age was 67.7 years (AVF, 67.3; AVG, 68.7 years; P < .001), 53.3% were men (AVF, 58.1%; AVG, 40.5%; P < .001), and 33.8% were obese (AVF, 33.6%; AVG, 34.4%; P = not significant). AVG placement was associated with a higher TDC removal at 1 (7.9% vs 3.1%; P < .001), 3 (47.8% vs 17.8%; P < .001), and 6 (60.6% vs 47.2%; P < .001) months. There was no difference at 9 months (AVG, 64.9% vs AVF, 62.3%; P = .06). The median time to TDC removal was lower in the AVG group (70 days vs 155 days; P < .001). Multivariable model found AVFs were associated with decreased odds of TDC removal at 3 (odds ratio, 0.22; P < .001) and 6 months (odds ratio, 0.54; P < .001). AVGs required more secondary procedures than AVFs at all time points up to 1 year and specifically had increased thrombectomy procedures (39.8% vs 11.5%; P < .001).
CONCLUSIONS:
In patients starting dialysis with a TDC, AVGs are associated with increased TDC removal and fewer catheter days compared with AVFs at up to 6 months. However, AVGs require more secondary procedures at all time points up to 1 year.
AuthorsAndrew E Leake, Theodore H Yuo, Timothy Wu, Larry Fish, Ellen D Dillavou, Rabih A Chaer, Steven A Leers, Michel S Makaroun
JournalJournal of vascular surgery (J Vasc Surg) Vol. 62 Issue 1 Pg. 123-7 (Jul 2015) ISSN: 1097-6809 [Electronic] United States
PMID25769391 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2015 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
Topics
  • Aged
  • Arteriovenous Shunt, Surgical (adverse effects)
  • Blood Vessel Prosthesis Implantation (adverse effects)
  • Catheterization, Central Venous (adverse effects, instrumentation)
  • Catheters, Indwelling
  • Central Venous Catheters
  • Databases, Factual
  • Device Removal
  • Female
  • Graft Occlusion, Vascular (etiology, physiopathology, surgery)
  • Humans
  • Logistic Models
  • Male
  • Multivariate Analysis
  • Odds Ratio
  • Renal Dialysis
  • Reoperation
  • Retrospective Studies
  • Risk Factors
  • Thrombectomy
  • Thrombosis (etiology, physiopathology, surgery)
  • Time Factors
  • Treatment Outcome
  • United States
  • Vascular Patency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: